This experiment was only feasible because the microfluidic chip-based technique for growing organotypic spheroids maintains tumor infiltrating T cells, including PD-L1+ T cells, as well as other immune cell types that are suppressed by PD-L1+ T cell activation. This evidence concerns the gene CD274 and neoplasm.